title: The anti-angiogenic activity of IL-12 is increased in iNOS-/- mice and involves NK cells.
abstract: We have previously reported that the in vivo transfer of murine interleukin-12 (IL-12) gene using a Semliki Forest virus vector induced tumor regression through inhibition of tumor blood vessel formation. To examine whether IL-12 anti-angiogenic activity interferes with the NO pathway, we used inducible nitric oxide synthase-deficient mice (iNOS-/-) and demonstrated that the anti-tumor effect of IL-12 is more pronounced in these mice. In addition, despite the increased level of intratumoral VEGF in iNOS-/- mice, IL-12 induced a stronger inhibition of blood vessel formation. Histological analysis of SFV-IL-12-treated tumors showed an increase in natural killer (NK) perivascular infiltration in iNOS-/- as compared to control mice. In vitro IL-12-stimulated murine splenic NK cells displayed significant killing activity towards established murine endothelial cells used as targets. These studies indicate that the anti-angiogenic activity of IL-12 interferes with iNOS pathway and involves NK cell recruitment.
authors.affiliation: INSERM U 753, Unité Immunologie des Tumeurs, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805, Villejuif, France.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Bielawska-Pohl
authors.forename: Séverine
authors.initials: S
authors.lastname: Blesson
authors.forename: Houssem
authors.initials: H
authors.lastname: Benlalam
authors.forename: Aurélie
authors.initials: A
authors.lastname: Trenado
authors.forename: Paule
authors.initials: P
authors.lastname: Opolon
authors.forename: Olivia
authors.initials: O
authors.lastname: Bawa
authors.forename: Valérie
authors.initials: V
authors.lastname: Rouffiac
authors.forename: Danuta
authors.initials: D
authors.lastname: Dus
authors.forename: Claudine
authors.initials: C
authors.lastname: Kieda
authors.forename: Salem
authors.initials: S
authors.lastname: Chouaib
mesh_terms: D000818:Animals; D042783:Endothelial Cells / Q000473:pathology; D055786:Gene Knockout Techniques; D018664:Interleukin-12 / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology* / Q000473:pathology; D008546:Melanoma, Experimental / Q000098:blood supply / Q000276:immunology* / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D009389:Neovascularization, Pathologic / Q000276:immunology* / Q000473:pathology; D009569:Nitric Oxide / Q000276:immunology; D052247:Nitric Oxide Synthase Type II / Q000235:genetics*; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology
chemical_list: D042461:Vascular Endothelial Growth Factor A; D018664:Interleukin-12; D009569:Nitric Oxide; D052247:Nitric Oxide Synthase Type II
references.citation: Transplantation. 1993 Oct;56(4):785-93
references.pmid: 8212196
references.citation: J Clin Invest. 1995 Jul;96(1):60-8
references.pmid: 7542286
references.citation: Cancer Immunol Immunother. 2010 Feb;59(2):267-77
references.pmid: 19669642
references.citation: J Biol Chem. 2003 Nov 21;278(47):46230-40
references.pmid: 12963737
references.citation: J Immunol. 1999 Dec 1;163(11):5877-82
references.pmid: 10570272
references.citation: Nat Med. 1998 Dec;4(12):1371-6
references.pmid: 9846573
references.citation: Biochem Biophys Res Commun. 2004 May 28;318(2):520-8
references.pmid: 15120632
references.citation: Melanoma Res. 2001 Dec;11(6):559-67
references.pmid: 11725202
references.citation: Am J Pathol. 2003 Mar;162(3):793-801
references.pmid: 12598314
references.citation: Blood. 1998 Sep 15;92(6):2093-102
references.pmid: 9731067
references.citation: Cancer Metastasis Rev. 1998 Mar;17(1):91-106
references.pmid: 9544425
references.citation: Clin Immunol. 2000 Jun;95(3):218-26
references.pmid: 10866129
references.citation: J Immunother. 2003 Jan-Feb;26(1):31-40
references.pmid: 12514427
references.citation: Ann Transplant. 1997;2(1):21-5
references.pmid: 9869837
references.citation: Transplantation. 2001 Nov 15;72(9):1563-71
references.pmid: 11707746
references.citation: In Vivo. 2002 Nov-Dec;16(6):439-45
references.pmid: 12494887
references.citation: Br J Cancer. 1995 Jul;72(1):41-4
references.pmid: 7541238
references.citation: J Immunol. 2000 Apr 15;164(8):4055-62
references.pmid: 10754298
references.citation: J Immunol. 2001 Mar 15;166(6):3890-9
references.pmid: 11238633
references.citation: Hum Immunol. 2009 Jun;70(6):375-82
references.pmid: 19480853
references.citation: Gene Ther. 1999 Apr;6(4):606-15
references.pmid: 10476220
references.citation: Nitric Oxide. 2006 Sep;15(2):103-13
references.pmid: 16504556
references.citation: Am J Physiol Cell Physiol. 2008 Nov;295(5):C1281-91
references.pmid: 18787079
references.citation: Nitric Oxide. 2008 Sep;19(2):217-24
references.pmid: 18515106
references.citation: Adv Immunol. 1999;72:209-53
references.pmid: 10361577
references.citation: J Exp Med. 1989 Sep 1;170(3):827-45
references.pmid: 2504877
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9114-9
references.pmid: 8799163
references.citation: Cancer Metastasis Rev. 1998 Mar;17(1):107-18
references.pmid: 9544426
references.citation: Clin Exp Metastasis. 1998 Oct;16(7):623-32
references.pmid: 9932609
references.citation: Clin Exp Metastasis. 2000;18(4):329-35
references.pmid: 11448064
references.citation: J Exp Med. 1998 Nov 2;188(9):1603-10
references.pmid: 9802972
references.citation: J Immunol. 2005 May 1;174(9):5573-82
references.pmid: 15843556
references.citation: J Immunol. 2009 Mar 1;182(5):2654-64
references.pmid: 19234159
references.citation: Trends Immunol. 2003 Nov;24(11):603-9
references.pmid: 14596885
references.citation: Cancer Res. 1995 Feb 15;55(4):727-30
references.pmid: 7531613
references.citation: Proc Natl Acad Sci U S A. 1995 May 9;92(10):4392-6
references.pmid: 7538668
references.citation: Cell Immunol. 2003 Mar;222(1):35-44
references.pmid: 12798306
references.citation: Biol Cell. 1993;79(3):209-18
references.pmid: 7516229
references.citation: Arch Immunol Ther Exp (Warsz). 2003;51(2):81-9
references.pmid: 12776907
references.citation: Endothelium. 2002;9(4):247-61
references.pmid: 12572856